Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Metadherin is a prognostic predictor of hepatocellular carcinoma after curative hepatectomy.

Ahn S, Hyeon J, Park CK.

Gut Liver. 2013 Mar;7(2):206-12. doi: 10.5009/gnl.2013.7.2.206. Epub 2013 Feb 7.

2.

CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection.

Hyeon J, Ahn S, Park CK.

Korean J Pathol. 2013 Feb;47(1):9-15. doi: 10.4132/KoreanJPathol.2013.47.1.9. Epub 2013 Feb 25.

3.

Prognostic Significance of BCL9 Expression in Hepatocellular Carcinoma.

Hyeon J, Ahn S, Lee JJ, Song DH, Park CK.

Korean J Pathol. 2013 Apr;47(2):130-6. doi: 10.4132/KoreanJPathol.2013.47.2.130. Epub 2013 Apr 24.

4.

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy.

Ha SY, Choi M, Lee T, Park CK.

Cancer Res Treat. 2016 Jan;48(1):180-9. doi: 10.4143/crt.2014.321. Epub 2015 Mar 18.

5.

Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.

Kim SH, Ahn S, Park CK.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):51-9.

PMID:
22251470
6.

Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.

Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH.

Korean J Intern Med. 2013 Jul;28(4):428-38. doi: 10.3904/kjim.2013.28.4.428. Epub 2013 Jul 1.

7.

High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.

Ha SY, Song DH, Lee JJ, Lee HW, Cho SY, Park CK.

Gut Liver. 2014 Nov;8(6):648-54. doi: 10.5009/gnl13406. Epub 2014 Oct 7.

8.

Prognostic significance of metadherin overexpression in hepatitis B virus-related hepatocellular carcinoma.

Gong Z, Liu W, You N, Wang T, Wang X, Lu P, Zhao G, Yang P, Wang D, Dou K.

Oncol Rep. 2012 Jun;27(6):2073-9. doi: 10.3892/or.2012.1749. Epub 2012 Mar 27.

PMID:
22470125
9.

Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.

Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG, Qu Q.

Pathol Res Pract. 2017 Jul;213(7):824-830. doi: 10.1016/j.prp.2017.03.002. Epub 2017 Mar 8.

PMID:
28554743
10.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
11.

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J.

Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.

12.

Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.

Kim BK, Han KH, Park YN, Park MS, Kim KS, Choi JS, Moon BS, Chon CY, Moon YM, Ahn SH.

J Surg Oncol. 2008 Mar 1;97(3):246-52.

PMID:
18095300
13.

Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.

Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Korenaga M, Mizokami M, Narimatsu H.

Liver Int. 2016 Feb;36(2):293-301. doi: 10.1111/liv.12907. Epub 2015 Jul 30.

PMID:
26134114
14.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

PMID:
23916473
15.

Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.

Ciria R, López-Cillero P, Gallardo AB, Cabrera J, Pleguezuelo M, Ayllón MD, Luque A, Zurera L, Espejo JJ, Rodríguez-Perálvarez M, Montero JL, de la Mata M, Briceño J.

Eur J Surg Oncol. 2015 Sep;41(9):1153-61. doi: 10.1016/j.ejso.2015.05.023. Epub 2015 Jun 12.

PMID:
26118317
17.

[Analysis of clinicopathological features and prognosis between alpha-fetoprotein negative and positive hepatocellular carcinoma patients after R0 radical hepatectomy].

Songlin A, Weiqi R, Liming W, Fan W, Weibo Y, Li F, Faqiang L, Fei T, Chao B, Jianxiong W.

Zhonghua Zhong Liu Za Zhi. 2015 Apr;37(4):308-11. Chinese.

PMID:
26462898
18.

Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.

Chan AW, Chan SL, Wong GL, Wong VW, Chong CC, Lai PB, Chan HL, To KF.

Ann Surg Oncol. 2015 Dec;22(13):4138-48. doi: 10.1245/s10434-015-4516-1. Epub 2015 Mar 24.

PMID:
25801356
19.

Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.

Lee JI, Lee JW, Kim JM, Kim JK, Chung HJ, Kim YS.

World J Gastroenterol. 2012 Sep 14;18(34):4751-7.

20.

Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma.

Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, Wu ZQ, Fan J, Qin LX, Zheng BH.

Cancer. 2001 Apr 15;91(8):1479-86.

PMID:
11301395

Supplemental Content

Support Center